ImmuneOnco Biopharmaceuticals (Shanghai) (FRA:R9Z) Operating Cash Flow per Share : €-0.04 (TTM As of Dec. 2024)

View and export this data going back to 2024. Start your Free Trial

What is ImmuneOnco Biopharmaceuticals (Shanghai) Operating Cash Flow per Share?

ImmuneOnco Biopharmaceuticals (Shanghai)'s operating cash flow per share for the six months ended in Dec. 2024 was €-0.00. ImmuneOnco Biopharmaceuticals (Shanghai)'s operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2024 was €-0.04.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 16.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for ImmuneOnco Biopharmaceuticals (Shanghai)'s Operating Cash Flow per Share or its related term are showing as below:

FRA:R9Z' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: 16.6 Med: 16.6 Max: 16.6
Current: 16.6

During the past 4 years, ImmuneOnco Biopharmaceuticals (Shanghai)'s highest 3-Year average Operating Cash Flow per Share Growth Rate was 16.60% per year. The lowest was 16.60% per year. And the median was 16.60% per year.

FRA:R9Z's 3-Year OCF Growth Rate is ranked better than
58.15% of 1221 companies
in the Biotechnology industry
Industry Median: 9.3 vs FRA:R9Z: 16.60

ImmuneOnco Biopharmaceuticals (Shanghai) Operating Cash Flow per Share Historical Data

The historical data trend for ImmuneOnco Biopharmaceuticals (Shanghai)'s Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ImmuneOnco Biopharmaceuticals (Shanghai) Operating Cash Flow per Share Chart

ImmuneOnco Biopharmaceuticals (Shanghai) Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Operating Cash Flow per Share

-0.07

-0.09

-0.13

-0.05

ImmuneOnco Biopharmaceuticals (Shanghai) Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Operating Cash Flow per Share	Get a 7-Day Free Trial			-0.05	-0.05	-0.08	-0.04	-

Competitive Comparison of ImmuneOnco Biopharmaceuticals (Shanghai)'s Operating Cash Flow per Share

For the Biotechnology subindustry, ImmuneOnco Biopharmaceuticals (Shanghai)'s Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ImmuneOnco Biopharmaceuticals (Shanghai)'s Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ImmuneOnco Biopharmaceuticals (Shanghai)'s Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where ImmuneOnco Biopharmaceuticals (Shanghai)'s Price-to-Operating-Cash-Flow falls into.

Save Embed

;

Save Embed

;

ImmuneOnco Biopharmaceuticals (Shanghai) Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

ImmuneOnco Biopharmaceuticals (Shanghai)'s Operating Cash Flow per Share for the fiscal year that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (A: Dec. 2024 )	=	Cash Flow from Operations (A: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2024 )
	=	-16.794	/	377.155
	=	-0.04

ImmuneOnco Biopharmaceuticals (Shanghai)'s Operating Cash Flow per Share for the quarter that ended in Dec. 2024 is calculated as

Operating Cash Flow per Share (Q: Dec. 2024 )	=	Cash Flow from Operations (Q: Dec. 2024 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2024 )
	=	-0.658	/	380.152
	=	-0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-0.04

ImmuneOnco Biopharmaceuticals (Shanghai) Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of ImmuneOnco Biopharmaceuticals (Shanghai)'s Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

ImmuneOnco Biopharmaceuticals (Shanghai) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ImmuneOnco Biopharmaceuticals (Shanghai) Inc (FRA:R9Z) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

01541:Hong Kong

Address

1000 Zhangheng Road, Unit 15, China (Shanghai) Pilot Free Trade Zone, Pudong New Area, Shanghai, CHN

Website

https://cn.immuneonco.com

ImmuneOnco Biopharmaceuticals (Shanghai) Inc is a science-driven biotechnology company dedicated to the development of immuno-oncology therapies. It is one of the few biotechnology companies globally adopting a systematic approach to harness both the innate and adaptive immune systems. It has developed a rich pipeline of 14 drug candidates with eight ongoing clinical programs, featured by a comprehensive innate-immunity-based asset portfolio. Its pipeline reflects its extensive understanding of the frontiers of cancer biology and immunology and its expertise in turning scientific research into drug candidates.

ImmuneOnco Biopharmaceuticals (Shanghai) Headlines

No Headlines